Back to top
more

OraSure Technologies (OSUR)

(Delayed Data from NSDQ)

$5.33 USD

5.33
410,822

+0.04 (0.76%)

Updated May 1, 2024 04:00 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value A Growth C Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 40% (151 out of 251)

Industry: Medical - Products

Better trading starts here.

Zacks News

OraSure Technologies (OSUR) Beats Q1 Earnings and Revenue Estimates

OraSure (OSUR) delivered earnings and revenue surprises of 66.67% and 0.88%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

OraSure Technologies (OSUR) Earnings Expected to Grow: What to Know Ahead of Q1 Release

OraSure (OSUR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

OraSure Technologies (OSUR) Q4 Earnings Miss Estimates

OraSure (OSUR) delivered earnings and revenue surprises of -57.14% and 7.35%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

OraSure Technologies (OSUR) Reports Next Week: Wall Street Expects Earnings Growth

OraSure (OSUR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

OraSure Technologies (OSUR) to Report Q4 Results: Wall Street Expects Earnings Growth

OraSure (OSUR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

ResMed (RMD) Q2 Earnings Surpass Estimates, Margins Rise

ResMed (RMD) reported second-quarter fiscal 2021 revenues of $800 million, up 9% from a year ago.

Smith+Nephew's (SNN) PICO sNPWT Study Outcome Encouraging

Smith+Nephew's (SNN) PICO Single Use Negative Pressure Wound Therapy System (sNPWT) considerably reduces surgical site infections complications and provides better patient outcome.

Allscripts (MDRX) Extends Tie-Up With US Orthopedic Alliance

Allscripts (MDRX) extends strategic partnership with US Orthopedic Alliance to form a more scalable orhopedic services technology platform.

Hill-Rom (HRC) to Boost Cardiology Portfolio with New Buyout

Hill-Rom's (HRC) acquisition of Bardy Diagnostics enables the former to expand into ambulatory cardiac monitoring space to accelerate digital health offering.

Aphria (APHA) Looks Good: Stock Adds 6% in Session

Aphria (APHA) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes.

OraSure Technologies (OSUR) Beats Q3 Earnings and Revenue Estimates

OraSure (OSUR) delivered earnings and revenue surprises of 114.29% and 11.38%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

Analysts Estimate OraSure Technologies (OSUR) to Report a Decline in Earnings: What to Look Out for

OraSure (OSUR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Company News for Oct 20, 2020

Companies in the news are: ONB, AMC, OSUR, BSRR

Implied Volatility Surging for OraSure (OSUR) Stock Options

Investors need to pay close attention to OraSure (OSUR) stock based on the movements in the options market lately.

OraSure Technologies (OSUR) Reports Q2 Loss, Lags Revenue Estimates

OraSure (OSUR) delivered earnings and revenue surprises of -77.78% and -14.54%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

Earnings Preview: OraSure Technologies (OSUR) Q2 Earnings Expected to Decline

OraSure (OSUR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Earnings Preview: OraSure Technologies (OSUR) Q1 Earnings Expected to Decline

OraSure (OSUR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

OraSure Technologies (OSUR) in Focus: Stock Moves 7.6% Higher

OraSure Technologies (OSUR) saw a big move last session, as its shares jumped nearly 8% on the day, amid huge volumes.

Analysts Estimate OraSure Technologies (OSUR) to Report a Decline in Earnings: What to Look Out for

OraSure (OSUR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

OraSure Technologies (OSUR) Q3 Earnings Surpass Estimates

OraSure (OSUR) delivered earnings and revenue surprises of 66.67% and -5.13%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

Earnings Preview: OraSure Technologies (OSUR) Q3 Earnings Expected to Decline

OraSure (OSUR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

OraSure Technologies (OSUR) Q2 Earnings Top Estimates

OraSure (OSUR) delivered earnings and revenue surprises of 133.33% and -6.94%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

Earnings Preview: OraSure Technologies (OSUR) Q2 Earnings Expected to Decline

OraSure (OSUR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

OraSure Technologies (OSUR) Reports Q1 Loss, Tops Revenue Estimates

OraSure (OSUR) delivered earnings and revenue surprises of 16.67% and 1.42%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

Analysts Estimate OraSure Technologies (OSUR) to Report a Decline in Earnings: What to Look Out for

OraSure (OSUR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.